[Effect of nebivolol on the level of constitutional, inducible, and total NO-synthase in serum of patients with type II diabetes mellitus].
Nebivolol (Nebilet) has been shown to promote increase in the content of inducible and total NO-synthase, which fact can have a positive effect on the functional condition of the endothelium and its antioxidant properties in patients with type II diabetes mellitus concurrent with arterial hypertension. It is recommended that nebivolol be taken in by the above patients to normalize arterial pressure.
Mohyl'nyts'ka
L A
LA
Man'kovs'kyĭ
B M
BM
D001578:Benzopyrans / Q000494:pharmacology* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism*; D004983:Ethanolamines / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D000068577:Nebivolol; D019001:Nitric Oxide Synthase / Q000096:biosynthesis* / Q000097:blood; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use
D001578:Benzopyrans; D004983:Ethanolamines; D007527:Isoenzymes; D014665:Vasodilator Agents; D000068577:Nebivolol; D019001:Nitric Oxide Synthase